Prostate cancer cells enhance interleukin‐15‐mediated expansion of NK cells

Abstract

To identify cytokines that can activate and expand NK cells in the presence of prostate cancer cells in order to determine whether these agents may be useful in future intra‐tumoural administration in pre‐clinical and clinical prostate cancer trials.